Provided by Tiger Trade Technology Pte. Ltd.

Camp4 Therapeutics Corp.

4.35
-0.1300-2.90%
Volume:28.58K
Turnover:126.18K
Market Cap:272.98M
PE:-1.96
High:4.52
Open:4.46
Low:4.26
Close:4.48
52wk High:7.75
52wk Low:1.41
Shares:62.75M
Float Shares:37.87M
Volume Ratio:0.28
T/O Rate:0.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2250
EPS(LYR):-2.6500
ROE:-545.85%
ROA:-45.25%
PB:-393.91
PE(LYR):-1.64

Loading ...

Company Profile

Company Name:
Camp4 Therapeutics Corp.
Exchange:
NASDAQ
Establishment Date:
2015
Employees:
48
Office Location:
One Kendall Square,3rd Floor,Building 1400 West,Cambridge,Massachusetts,United States
Zip Code:
02139
Fax:
- -
Introduction:
CAMP4 Therapeutics Corporation was incorporated in Delaware in 2015 and began operations in 2016. It is a clinical-stage biopharmaceutical company pioneering the discovery and development of RNA-based regulatory therapies designed to upregulate gene expression and restore healthy protein levels for the treatment of various genetic diseases. Their proprietary RNA-Actuating Platform (RAP) enables rapid, systematic identification and characterization of active regulatory elements and tens of thousands of druggable enhancer and promoter regRNA sequences that control protein-coding genes.

Directors

Name
Position
Josh Mandel Brehm
President, Chief Executive Officer and Director
Steven Holtzman
Chair of the Board and Director
Amir Nashat
Director
Andrew J. Schwab
Director
Douglas Williams
Director
Michael Higgins
Director
Murray Stewart
Director
Richard Young
Director

Shareholders

Name
Position
Josh Mandel Brehm
President, Chief Executive Officer and Director
David Bumcrot
Chief Scientific Officer and Senior Vice President of Research
Kelly Gold
Chief Financial Officer
Yuri Maricich
Chief Medical Officer